# Spyre Therapeutics, Inc.: Form DEF 14A, filed Apr 10, 2026

- Company: [Spyre Therapeutics, Inc.](/companies/syre.md) (CIK 1636282)
- Form: DEF 14A
- Filed: 2026-04-10
- Accepted by EDGAR: Apr 10, 2026, 16:01 ET
- Period: 2026-05-27
- Accession: 0001636282-26-000039
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1636282/000163628226000039/syre-20260410.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1636282/000163628226000039/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1636282/000163628226000039/syre-20260410.htm

Filed Apr 10, 2026.
Source: SEC EDGAR, the filing index for accession 0001636282-26-000039. Last ingested by Listed: Nov 3, 2026, 18:46 ET. No prices; not investment advice.